Prohibits sale of cosmetic products and personal care products containing 1,4-dioxane.
Impact
This legislation marks a significant shift in state law concerning the regulation of hazardous chemicals in consumer products. By enforcing these prohibitions, the bill aims to safeguard public health and ensure that consumers are not exposed to potentially harmful substances through everyday products. The requirement for manufacturers to apply for waivers indicates an understanding of the challenges businesses might face in rapidly phasing out such chemicals, thereby allowing room for compliance while still prioritizing health and safety.
Summary
Senate Bill S2946 aims to prohibit the sale of cosmetic products and personal care products that contain 1,4-dioxane, a chemical known for its potential harmful effects and categorized as a possible human carcinogen. The bill mandates that regulations regarding allowable trace concentrations of 1,4-dioxane in these products be established by the Commissioner of Environmental Protection. Specifically, the bill proposes that the allowable trace concentration for cosmetic products shall not exceed 10 parts per million, while personal care products shall initially be capped at two parts per million, reducing to one part per million after two years.
Contention
Debate over the bill may center on balancing health initiatives with industry impacts. While supporters argue that eliminating 1,4-dioxane aligns with public health interests and safer consumer products, opponents may voice concerns regarding the cost implications for manufacturers and the potential for product availability issues. Additionally, some may question the practicality of transitioning away from an established chemical used in many cosmetic and personal care items, thus igniting discussions on the feasibility of alternative solutions.